How to Validate Predictive Immunohistochemistry Testing in Pathology? A Practical Approach Exploiting the Heterogeneity of Programmed Death Ligand-1 Present in Non-Small Cell Lung Cancer

Arch Pathol Lab Med. 2019 Jan;143(1):11-12. doi: 10.5858/arpa.2018-0410-ED. Epub 2018 Oct 11.
No abstract available

Publication types

  • Editorial

MeSH terms

  • B7-H1 Antigen / metabolism*
  • Biomarkers, Tumor / metabolism*
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / pathology*
  • Pathology
  • Validation Studies as Topic*

Substances

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • CD274 protein, human